Nebraska vaccine shows strong efficacy

Bird flu vaccines for cattle sound niche, but the stakes are pretty broad. H5N1 is no longer just a poultry problem — it jumped into U.S. dairy herds in 2024, hit farm workers, and exposed a big gap in how little protection cattle actually have. Now a University of Nebraska–Lincoln team says it has an experimental vaccine that worked well in mice and produced strong immune responses in calves. The point is not that farms are about to start using it tomorrow. The point is that someone finally has a cattle-focused approach that looks plausible in the species that matters. (nature.com) ### What exactly did Nebraska build? The team — Eric Weaver, Joshua Wiggins, and Adthakorn Madapong — built a “centralized consensus” H5 vaccine, basically a design meant to sit near the middle of many H5 strains instead of matching just one narrow version. They delivered it with adenoviral vectors in a prime-boost setup, and they switched vector serotypes between doses to keep the immune system from neutralizing the delivery vehicle itself. That is a t(nature.com)d protection without the platform getting in its own way. (nature.com) ### Why use two routes? Because H5N1 causes two different kinds of trouble. One is disease inside the animal. The other is spread from animal to animal through the respiratory tract. So the Nebraska group used an intramuscular shot to build systemic immunity and an intranasal dose to build mucosal immunity in the airways. Think of it as locking the house and also guarding the front porch. One defense helps stop severe illness. The other may help stop shedding and transmission. (news.unl.edu) ### What worked in mice? The cleanest result came from the mouse challenge experiments. Vaccinated mice were fully protected against lethal infection from multiple divergent H5N1 strains, including a 2024 bovine isolate from Ohio. That matters because “works against one lab strain” is a much weaker claim than “works against divergent strains.” The whole point of the consensus design is breadth, and the mouse data are the best early evidence that the breadth might be real. (nature.com) ### What happened in calves? The cattle data are earlier-stage, but still important. The researchers vaccinated dairy calves at 1 week old, then gave a booster 4 weeks later. The calves produced strong humoral and cellular immune responses, and the paper says the immune patterns were consistent enough across mice and calves to support using the mouse model as a guide for bovine protection. That does not mean the calves were challenge-tested the same way(nature.com)uraging. (news.unl.edu) ### Why is cattle vaccination such a big deal? Because there is still no licensed H5N1 vaccine for cattle. And once the virus established itself in dairy herds, the risk picture changed. Infected cows can mean production losses, farm-to-farm spread, and more opportunities for the virus to adapt in mammals. That last part is what keeps public-health people up at night. Every mammalian infection is another roll of the dice. (news.unl.edu) ### So is this ready for farms? Not yet. This is still preclinical work, and the npj Vaccines paper was posted in an early-access form in April 2026. The Nebraska team is looking for funding and partners to push the vaccine further, including wider evaluation and possibly a multispecies version. So the real news is not “problem solved.” It is “there is now a serious candidate worth advancing.” (nature.com) because it matches the problem to the biology. H5N1 in cattle is a respiratory and farm-transmission problem, not just a blood-antibody problem. A vaccine that can protect the body and the airways is exactly the kind of thing researchers have been missing. The catch is the usual one — early success is not the same as a licensed product. But this is the strongest sign yet that a cattle-specific bird flu vaccine could actually be built. (nature.com)